Cognios Beta Neutral Large Cap Fund’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$522K Sell
6,541
-852
-12% -$65.1K 0.68% 55
2023
Q4
$584K Sell
7,393
-474
-6% -$33.7K 0.76% 39
2023
Q3
$549K Sell
7,867
-1,162
-13% -$82.3K 0.71% 68
2023
Q2
$624K Sell
9,029
-654
-7% -$46.5K 0.72% 74
2023
Q1
$723K Buy
9,683
+544
+6% +$45.6K 0.69% 73
2022
Q4
$852K Buy
+9,139
New +$882K 0.82% 62

Other funds holding CVS

Cognios Beta Neutral Large Cap Fund's CVS Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its CVS Health (CVS) stake by 12% in Q1 2024, selling an estimated $65.1K and leaving 6,541 shares worth $522K. The position accounts for 0.68% of the portfolio, ranked #55.

Cognios Beta Neutral Large Cap Fund first reported a position in CVS in Q4 2022 and has held it in 6 quarters since. The position peaked at $852K in Q4 2022. 2,177 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Cognios Beta Neutral Large Cap Fund held 6,541 shares of CVS Health worth $522K as of Q1 2024.
  • Cognios Beta Neutral Large Cap Fund sold 852 CVS Health shares in Q1 2024, an estimated $65.1K.
  • CVS Health made up 0.68% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #55 holding.
  • Cognios Beta Neutral Large Cap Fund first reported a position in CVS Health in Q4 2022 and has held it in 6 quarters since.
  • Cognios Beta Neutral Large Cap Fund's CVS Health position peaked at $852K in Q4 2022.
  • 2,177 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.